Evaluating the Quality of Interview Data Collected by Teratology Information Services About Pregnancy Outcomes, Maternal and Infant Health, Following Medication Use During Pregnancy and Lactation

ICR 200910-0920-007

OMB: 0920-0838

Federal Form Document

Forms and Documents
Document
Name
Status
Form
New
Form
New
Form
New
Form
New
Form
New
Form
New
Form
New
Form
New
Form
New
Form
New
Supporting Statement B
2009-12-14
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supplementary Document
2009-09-30
Supporting Statement A
2009-12-14
ICR Details
0920-0838 200910-0920-007
Historical Active
HHS/CDC
Evaluating the Quality of Interview Data Collected by Teratology Information Services About Pregnancy Outcomes, Maternal and Infant Health, Following Medication Use During Pregnancy and Lactation
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 01/08/2010
Retrieve Notice of Action (NOA) 10/21/2009
  Inventory as of this Action Requested Previously Approved
01/31/2013 36 Months From Approved
2,094 0 0
516 0 0
0 0 0

The US does not conduct comprehensive monitoring for pregnancy or infant outcomes related to medication exposures. The FDA collects adverse health event reports, but the time between pregnancy exposures and outcomes makes underreporting a limitation. Teratology Information Services (TIS)in the US and Canada use specialists to provide consultation and risk assessment about environmental exposures during pregnancy and breastfeeding, including medications, herbal preparations, and dietary supplements. They have direct contact with pregnant and breastfeeding women, and because women contact them for information about these exposures, they are in a unique position to monitor the effects of medication use during pregnancy and lactation. The goal of this project is to assess the quality of information on pregnancy outcomes and maternal and infant health following medication use during pregnancy and lactation that can be obtained from maternal interviews by typical TIS in the US.

US Code: 42 USC 247b-4 Name of Law: Children's Health Act of 2000
   US Code: 42 USC 241 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  72 FR 65737 11/23/2007
74 FR 49381 09/28/2009
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,094 0 0 2,094 0 0
Annual Time Burden (Hours) 516 0 0 516 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new ICR. Please note that OMB waived the republication of the 60 day FRN after discussions and the retraction of a broader, yet similar project earlier this year.

$87,500
Yes Part B of Supporting Statement
Yes
Uncollected
Uncollected
No
Uncollected
Maryam Daneshvar 4046394604

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/21/2009


© 2024 OMB.report | Privacy Policy